Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death-Reference-Cited by-同舟云学术

Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death

Published:2024-04-04 Issue:15 Volume:16 Page:19472-19479
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Yao Xikuang¹^ORCID,Sun Changrui¹,Xiong Fei¹,Zhang Weina¹^ORCID,Yao Wenjing²,Xu Yinghui²,Fan Wenpei²^ORCID,Huo Fengwei¹^ORCID

Affiliation:

1. School of Flexible Electronics (Future Technologies) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211816, China

2. State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, China

Funder

China Pharmaceutical University

Natural Science Foundation of Jiangsu Province

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Natural Science Foundation of the Jiangsu Higher Education Institutions

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c00166

Reference26 articles.

1. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy

2. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

3. New opportunities and old challenges in the clinical translation of nanotheranostics

4. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

5. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy